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Abstract. Magnetic Resonance Spectroscopy visible mobile
lipids are considered important markers in the diagnosis of
human cancer and are thought to be closely involved in various
aspects of tumour transformation, such as cell proliferation,
necrosis, apoptosis, hypoxia and drug resistance. A method
allowing the straightforward identification of the lipid classes
contributing to the mobile lipids in human malignant tissues
is highly advisable. Ex vivo High Resolution Magic Angle
Spinning Magnetic Resonance Spectroscopy was done directly
on human cerebral, renal and colorectal malignant tissue
specimens. A diffusion edited sequence, based on stimulated
echo and bipolar gradient pulses, was used to characterize
molecules with low diffusion rates, arising from mobile lipid
components. Cholesterol, triglycerides and phosphatidylcholine
are simultaneously detected and all contribute to the mobile
lipid resonances present in malignant glioma and clear cell
renal carcinoma tissue specimens spectra. On the contrary,
papillary cell renal carcinoma spectrum is predominated by
phosphatidylcholine resonances and that of colorectal adeno-
carcinoma is characterized by signals arising from triglycerides.
Ex vivo diffusion edited High Resolution Magic Angle
Spinning Magnetic Resonance Spectroscopy, done on intact
tissue, is a powerful analytical tool to obtain a simple and
immediate identification of mobile lipid components. This
can offer a significant contribution to better understanding
their involvement in cancer tissues. Furthermore, ex vivo high
resolution spectroscopic measurements allow to improve the
interpretation of in vivo Magnetic Resonance spectra,
increasing its clinical potentiality.
Introduction
Great interest has been dedicated to Magnetic Resonance
Spectroscopy (MRS) visible mobile lipids (MLs), which
significance in life and death of cells has been highlighted by
Hakumaki and Kauppinen (1). Lipid deposits in human cells
and tissues are revealed and identified by MRS. These
compounds are thought to originate mainly from triglycerides
(TG) fatty acid (FA) chains with a lesser contribution from
cholesteryl esters (CholE) (1). In the early 80s, Mountford
and Wright hypothesized that MLs arise from neutral lipids
located in plasma membrane (2). Afterwards, other authors
have speculated that MLs exist in cytosolic lipid droplets (3-
5). Several MRS studies have clearly elucidated how these
lipids are closely involved in various important aspects of
tumour transformation, such as cell proliferation, necrosis,
apoptosis, hypoxia and drug resistance (6-10). Moreover, MLs
are supposed to have clinical potential in brain cancer
treatment response detection (11-14). Despite the large
number of MRS studies on experimental and human cancer
(1-14), the exact MLs metabolic origin is still debated,
therefore, a method allowing the straightforward character-
ization of these important tissue components, is highly
advisable. In this study, the possibility to perform the simple
and simultaneous identification of cholesterol (Chol) and/or
CholE, TG and phospholipids (Ph) in human malignant
neoplasms, is described. Cancer tissue specimens were studied
by ex vivo High Resolution Magic Angle Spinning (HR-MAS)
MRS, using a diffusion edited sequence, which allowed the
separation of molecules characterized by low diffusion rates.
To our knowledge, a similar experiment on different human
cancer tissues, has not yet been reported in literature.
ONCOLOGY REPORTS  22:  1493-1496,  2009
Identification of mobile lipids in human cancer tissues 
by ex vivo diffusion edited HR-MAS MRS
VALERIA RIGHI1,2,  ADELE MUCCI2,  LUISA SCHENETTI2,  ANTONELLA BACCI3,  RAFFAELE AGATI3,  
MARCO LEONARDI3,  RICCARDO SCHIAVINA4,  GIUSEPPE MARTORANA4,  GIUSEPPINA LIGUORI5,  
CARLO CALABRESE5,  ELISA BOSCHETTI1,  SERGIO BONORA1 and VITALIANO TUGNOLI1
1Dipartimento di Biochimica ‘G. Moruzzi’, Università di Bologna, Via Belmeloro 8/2, 40126 Bologna; 
2Dipartimento di Chimica, Università di Modena e Reggio Emilia, Via G. Campi 183, 41100 Modena; 
3Dipartimento di Neuroscienze, Divisione e Cattedra di Neuroradiologia, Università di Bologna, Ospedale Bellaria, 
Via Altura 3, 40139 Bologna; 4Dipartimento di Scienze Chirurgiche Specialistiche e Anestesiologiche, Sezione di Urologia, 
Università di Bologna, Policlinico S. Orsola-Malpighi, Via P. Palagi 9; 5Dipartimento di Medicina Interna e Gastroenterologia, 
Università di Bologna, Policlinico S. Orsola-Malpighi, Via G. Massarenti 9, 40138 Bologna, Italy
Received June 10, 2009;  Accepted July 23, 2009
DOI: 10.3892/or_00000592
_________________________________________
Correspondence to: Dr Vitaliano Tugnoli, Dipartimento di
Biochimica ‘G. Moruzzi’, Università di Bologna, Via Belmeloro 8/2,
40126 Bologna, Italy
E-mail: vitaliano.tugnoli@unibo.it
Key words: ex vivo, diffusion, High Resolution Magic Angle
Spinning, Magnetic Resonance Spectroscopy, mobile lipids,
cancer
1493-1496  8/10/2009  09:10 Ì  Page 1493
Materials and methods
Magnetic Resonance Imaging (MRI) and localized single
voxel in vivo 1H-MRS were performed with a 3 Tesla whole-
body scanner (General Electric Medical Systems, Milwaukee,
WI) on two patients affected by cerebral lesion, following the
routine standard clinical protocol previously described (15).
After MRI and in vivo MRS the patients underwent surgery
and two adjacent samples were obtained. One section was used
for routine histopathology and revealed a malignant glioma
in both cases. The second sample was used for HR-MAS
measurements. Specimens were also collected from three
patients undergoing radical nephrectomy for solid masses.
Renal lesions were sorted by microscopy: two were classified
as clear cell and one turned out to be a papillary cell renal
carcinoma. In this study, a tissue specimen obtained from a
patient who underwent surgery for colorectal adenocarcinoma
has been also included. All patients gave written informed
consent to participate to the study which was approved by the
local research Ethics Committees.
The six tissue samples were quickly frozen in liquid
nitrogen and stored at -85˚C until MRS analyses. Ex vivo 1H
HR-MAS MR spectra were recorded with a Bruker Avance400
spectrometer (Bruker BioSpin, Karlsruhe, Germany) equipped
with a 4-mm dual 1H/13C HR-MAS probe, operating at
400.13 MHz. Samples were spun at 4000 Hz and 1H MR
spectra were acquired by using a sequence for diffusion
measurements (16), based on stimulated echo and bipolar
gradient pulses, with big delta 200 ms, eddy current delay Te
5 ms, little delta 2*2 ms, fine shaped gradient with 32 G/cm
followed by a 200 μsec delay for gradient recovery, 8 kHz
spectral width, 8k data point and 256 scans. The assignments
were in agreement with the literature and were confirmed by
comparison of the MR spectra of Sigma standard lipid
compounds [Chol, CholE, TG, phosphatidylcholine (PhC),
saturated fatty acids and poly-unsaturated fatty acids (PUFAs)].
Results and discussion
Ex vivo HR-MAS MRS, introduced in 1997 by Cheng et al
(17), has become essential to outline intact human tissues
metabolic profiles (9,18-22). In a previous study performed
in our laboratory (22), using HR-MAS technique, we  charac-
terized the human gastric adenocarcinomas biochemical
profile. In particular, a diffusion edited sequence (16) allowed
us to obtain spectra displaying broad resonances of molecules
characterized by low diffusion rates, deriving from mobile
lipids, which were identified as saturated and unsaturated
FA chains, almost exclusively esterified in TG. Since the
importance of MLs in cancer (1-14), we have undertaken a
diffusion edited HR-MAS MRS study on different human
neoplasms, in order to indentify accurately the lipid classes
contributing to the MLs resonances in human malignant tissues.
Fig. 1 shows malignant glioma ex vivo diffusion edited 1H
HR-MAS MR spectrum. In the window, the axial T2-wheighted
MR image and localized in vivo 1H MR spectrum of the same
lesion, obtained before surgery, are also reported. In in vivo
spectrum, two signals at 1.30 and 0.90 ppm are present, and
are assigned to methylene -(CH2)n- and terminal methyl -CH3
protons, respectively, in FA chains. These signals, in brain
neoplasm in vivo MR spectra, are generally attributed to the
presence of FA chains arising from MLs, which are associated
with tumour aggression and are considered markers of high
grade malignant lesions (23); however, these resonances do
not give information on the lipid classes contributing to MLs
composition.
The analysis of the ex vivo diffusion edited 1H HR-MAS
MR spectrum is considered largely helpful. Indeed, in Fig. 1,
besides several resonances pertaining to FA chains, signals
arising from neutral (TG and Chol and/or CholE) and polar
(Ph) lipid moieties, are clearly observed. Eight signals [proton
assignments are reported in brackets] resonating at 0.90
[terminal methyls, y-CH2-CH3], 1.30 [methylenes, x-CH2-
(CH2)n-CH2-y and x-CH2-(CH2)n-CH2-y], 1.58 [ß-methylenes,
x-CH2-CH2-CH2-CO-y], 2.05 [mono-allylic methylenes, x-
CH2-CH=CH-y and x-CH2-CH=CH-CH2-CH2-y], 2.30 [·-
methylenes, x-CH2-CH2-CH2-CO-y], 2.70-2.80 [di-allylic
methylenes, =CH-CH2-CH= and x-CH=CH-(CH2-CH=CH)n-y]
and 5.30 [vinyl protons, x-CH=CH-(CH2-CH=CH)n-y, x-CH2-
CH=CH-y and x-CH2-CH=CH-CH2-CH2-y] ppm indicate the
presence of saturated and unsaturated FA chains (19,24,25).
Other resonances arising from Chol and/or CholE, Ph and
TG moieties, are detected. These lipids are clearly identified,
according to the literature (19,24,25) and to the comparison of
single standard spectra, based on the following signals: 0.68
[Chol backbone, 18-CH3], 0.90 [Chol backbone, 21-CH3, 9-
CH, 19-CH3], 1.04 [Chol backbone, 1-CH2, 14-CH, 17-CH,
22-CH2, 23-CH2 and 24-CH2], 1.65 [Chol backbone, 7-CH2,
15-CH2 and 25-CH], 3.04 [phosphatidylethanolamine (PhE)
plasmalogen, -CH2-CH2-NH2], 3.25 [PhC, trimethyammonium,
-N+(CH3)3], 4.08 and 4.28 [TG, bonded glycerol, CH2OCOR1-
CHOCOR2-CH2OCOR3] and 5.22 [TG, bonded glycerol,
CH2OCOR1-CHOCOR2-CH2OCOR3].
Other malignant glioma ex vivo diffusion edited 1H HR-
MAS MR spectra (data not shown) are quite similar to that
reported in Fig. 1, the only difference being a more intense
trimethylammonium -N+(CH3)3 choline residue signal at
3.25 ppm, indicating a larger amount of PhC. In both cases,
diffusion edited HR-MAS sequence, due to higher signal-to-
noise ratio and to the fact that signals are not spread over the
whole spectrum, as in in vivo MRS, allows to determine that
MR visible MLs resonances receive contribution from: i) FA
esterified in TG; ii) FA esterified in PhC; iii) Chol, which has
been found to be present as CholE in experimental and human
gliomas (11). This opportunity appears particularly important
considering, for example, that lipid content, revealed by a
conventional single pulse HR-MAS MRS experiment, only
from the FA signals at 1.30 and 0.90 ppm, has been found to
be an important factor to separate the metastasis spectra
originating from different primary tumours and was also
correlated with clinical outcome (19).
All the above-mentioned lipid resonances, arising from
saturated and unsaturated FA chains, TG, PhC and Chol
and/or CholE moieties, are also present in Fig. 2a, displaying
the clear cell renal carcinoma ex vivo diffusion edited 1H
HR-MAS MR spectrum. The profile of this lesion, both for
signal intensities and frequencies, is very similar to the one
of the other clear cell carcinoma. In the spectrum in Fig. 2a,
signals arising from cholesterol backbone, which we have
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previously found to be present as cholesteryl oleate in the
chloroform/methanol extracts (26), are particularly evident.
On the contrary, resonances due to Chol and/or CholE are
absent, and those arising from TG are negligible, in papillary
cell renal carcinoma spectrum (Fig. 2b). In fact, the diffusion
edited spectrum of this lesion shows signals due to saturated
and unsaturated FA chains which are esterified in PhC, as
inferred by the strong resonance at 3.25 ppm coming up from
the trimethylammonium -N+(CH3)3 choline residue. Weak
resonances in the 3.50-4.50 ppm region are also present and
assigned to bonded amino acids (AA) in small oligopeptides
(22). It should be remarked that ratio between FA methyl [-
CH3] and FA methylene [-(CH2)n-] signal is bigger than the
one present in other spectra, showing the contribution of
methyl from AA in the 0.9 ppm resonance.
Colorectal adenocarcimoma 1H HR-MAS MR spectrum is
reported in Fig. 2c. Signals due to saturated and unsaturated
FA chains esterified in TG, as the main lipid component
characterizing the malignant tissue, are observed. On the
contrary, resonances typical of Ph and Chol moieties are
negligible or absent, respectively. The strong signal at 3.70 ppm
arises from polyethylene glycol (PEG), present in pharma-
ceutical preparation used for colon preparation.
As above described, a careful inspection of the human
neoplastic lesions ex vivo diffusion edited HR-MAS MR
spectra (Figs. 1 and 2), show clear signals arising from
different groups of saturated and unsaturated FA chains. The
resonance at 2.80 ppm, attributable to methylene protons
between two double bonds (=CH-CH2-CH=), is particularly
intense in high grade glioma spectrum (Fig. 1) and indicates
the presence of PUFAs (12,13,24,25,26). Monitoring these
attracting markers could be of great utility. Indeed, PUFAs
are strongly implicated in apoptotic processes occurring after
anti-cancer gene therapy (12,13) and they are supposed to have
clinical potential in brain cancer treatment response detection
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Figure 1. Ex vivo diffusion edited 1H HR-MAS MR spectrum of a malignant glioma; in the window, the axial FSE T2-wheighted MR image and the localized
in vivo 1H MR spectrum of the same lesion, are also reported.
Figure 2. Ex vivo diffusion edited 1H HR-MAS MR spectra of: (a) clear
cell renal carcinoma; (b) papillary cell renal carcinoma; (c) colorectal
adenocarcinoma; *residual water peak; **PEG.
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(11-14). Even if TG and CholE are considered the predominant
lipid groups contributing to the MRS visible MLs in human
neoplastic tissue (1), from our ex vivo HR-MAS MRS findings
it is evident that the contribution of mobile PhC cannot be
overlooked.
Concluding, this preliminary study clearly indicates that
diffusion edited HR-MAS MRS has the potential to bear novel
implications for a better understanding of lipid biochemistry in
cancer. Further studies on the direct correlation between all
types of MLs components (FA, TG, Ph, Chol and/or CholE
and PUFAs) characterizing human neoplastic tissues, with
different aspects of tumour transformation, will be possible.
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